Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
Immunicum AB (publ), which develops therapeutic cancer vaccines, initiated a clinical phase I/II-trial in renal cell carcinoma in February 2012. The Company has now submitted an application to the Medical Products Agency for permission to start another clinical phase I/II-trial in liver cancer. The study will include a total of 12 patients, and is planned in cooperation with the Transplantation Centre at Sahlgrenska University Hospital in Gothenburg, Sweden, where Dr Magnus Rizell is responsible for the trial. The first patient is expected to be included around the turn of 2013/2014.
Help employers find you! Check out all the jobs and post your resume.
